Letters by company
Five9, Inc.
1 letter discussing FIVN. Everything written about it on this site is on its ticker page.
- Polen Capital 5Perspectives Growth Opportunities 5Perspectives Small Growth Commentary Polen 5Perspectives Small Growth shifted capital from AI infrastructure and electrification suppliers toward AI appliers, while raising Health Care Innovation exposure and reducing Industrials. Twist Bioscience, RingCentral, and Five9 benefited from AI-related product demand and stronger outlooks, while Terawulf, nLight, and Brookdale Senior Living faced monetization, supply-chain, and near-term growth concerns. 3Q 2026 BKD $2.5BFIVN $2.7BLASR $2.1B
